Bill

Bill > S2051


US S2051

Strengthening Average Sales Price Reporting Act of 2019


summary

Introduced
06/28/2019
In Committee
06/28/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A bill to amend XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program. This bill requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.

AI Summary

This bill, the Strengthening Average Sales Price Reporting Act of 2019, requires certain manufacturers of drugs covered under Medicare to report pricing information, including average sales price, total units, and wholesale acquisition cost, to the Centers for Medicare & Medicaid Services. Manufacturers that do not have a Medicaid drug rebate agreement must report this data, which is subject to audit and verification by the Secretary. Failure to report or providing false information can result in civil monetary penalties. The bill also requires the Inspector General to assess the accuracy of the reported information and provide recommendations to Congress.

Committee Categories

Budget and Finance

Sponsors (2)

Last Action

Read twice and referred to the Committee on Finance. (on 06/28/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...